Concetta Fierravanti-Wells (NSW, Liberal Party, Minister for International Development and the Pacific) Share this | Hansard source

I thank Senator Hinch for that question. We have been monitoring urogynecological meshes since 2008 and we have been continuing to provide information on our website for the public and health professionals. On 28 November, the TGA published a statement advising the public of further regulatory action in response to a review of new information. A list of cancelled and current devices was included. Information that has been published in the past, in 2016 and 2017, has changed the risk-benefit profile to 'unfavourable' for devices used transvaginally for pelvic organ prolapse and many incision slings for stress urinary incontinence. If a patient has an implanted urogynecological mesh causing any symptoms, including pain, or if a patient has concerns about any implanted device, they should contact their surgeon. Senator Hinch, I'm happy to take on notice more details in relation to your specific question. I'm only able, at this point, to provide you with general information, but I'm happy to take the details on notice.